Literature DB >> 8370620

Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification.

E van den Berg1, A H van der Hout, J W Oosterhuis, S Störkel, T Dijkhuizen, A Dam, H M Zweers, H J Mensink, C H Buys, B de Jong.   

Abstract

Renal-cell carcinomas (RCC) are clinically, histologically and cytogenetically very heterogeneous. The present histological WHO classification shows no clear correlation between histologic subtypes and specific chromosomal abnormalities. In 1986, a new classification was proposed by Thoenes and Störkel based on the cell type from which the tumor arises. They distinguish 5 cell types: clear-cell, chromophilic, chromophobic, ductus Bellini and oncocytic. Results of 105 primary tumors show that, in this new classification, there is a correlation between different subtypes of renal-cell tumor and specific chromosomal abnormalities at a microscopic and/or molecular level. The clear-cell compact type shows structural aberrations of chromosomes I, 3, 4, 5q, 6, 10q, 11q and 12q, together with polysomy of chromosomes X, 4, 5, 7, 10, 12, 15, 16, 19, 20, 21 and 22, monosomy of chromosomes 3, 8, 9, 13, 14, and loss of Y. The main characteristics of the chromophilic tubulo-papillary type are trisomies 7 and 17, and loss of the Y-chromosome. Chromophobic carcinoma seems to be correlated with, inter alia, polysomy 7, trisomies 12, 16, 18, 19, structural abnormalities of 11q, and telomeric associations. Oncocytomas do not reveal any specific chromosomal anomaly, except for trisomy 7. Loss of heterozygosity on 3p is only found in the clear-cell compact type. Some specific chromosomal abnormalities correlate with a particular grade of the tumor. These correlations support the hypothesis that specific chromosomal abnormalities play a role in the histogenesis and oncogenesis of RCC. They may be important for tumor diagnosis and clinical prognosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370620     DOI: 10.1002/ijc.2910550210

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.

Authors:  Amy E Krambeck; R Houston Thompson; Haidong Dong; Christine M Lohse; Eugene S Park; Susan M Kuntz; Bradley C Leibovich; Michael L Blute; John C Cheville; Eugene D Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-23       Impact factor: 11.205

2.  Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization.

Authors:  M R Speicher; B Schoell; S du Manoir; E Schröck; T Ried; T Cremer; S Störkel; A Kovacs; G Kovacs
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

Review 3.  Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.

Authors:  Simon Chowdhury; Marc R Matrana; Christopher Tsang; Bradley Atkinson; Toni K Choueiri; Nizar M Tannir
Journal:  Hematol Oncol Clin North Am       Date:  2011-08       Impact factor: 3.722

4.  Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations.

Authors:  P Hadaczek; J Podolski; A Toloczko; G Kurzawski; A Sikorski; P Rabbitts; K Huebner; J Lubinski
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

5.  Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.

Authors:  M A Weterman; M Wilbrink; A Geurts van Kessel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

6.  Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction.

Authors:  Y Suzuki; G Tamura; C Maesawa; T Fujioka; T Kubo; R Satodate
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up.

Authors:  Marie Dvorakova; Rajiv Dhir; Sheldon I Bastacky; Kathleen M Cieply; Marie B Acquafondata; Carol R Sherer; Tracy L Mercuri; Anil V Parwani
Journal:  Diagn Pathol       Date:  2010-05-24       Impact factor: 2.644

8.  Morphological classification of renal cancer.

Authors:  S Störkel; E van den Berg
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

9.  Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma.

Authors:  C D Gerharz; R Moll; S Störkel; U Ramp; B Hildebrandt; G Molsberger; P Koldovsky; H E Gabbert
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

10.  Sub-typing of renal cell tumours; contribution of ancillary techniques.

Authors:  Dinesh Pradhan; Nandita Kakkar; Amanjit Bal; Shrawan Kumar Singh; Kusum Joshi
Journal:  Diagn Pathol       Date:  2009-06-28       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.